HU169926B - - Google Patents

Info

Publication number
HU169926B
HU169926B HUSA2805A HUSA002805A HU169926B HU 169926 B HU169926 B HU 169926B HU SA2805 A HUSA2805 A HU SA2805A HU SA002805 A HUSA002805 A HU SA002805A HU 169926 B HU169926 B HU 169926B
Authority
HU
Hungary
Application number
HUSA2805A
Other languages
Hungarian (hu)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH838074A external-priority patent/CH599160A5/de
Priority claimed from CH838174A external-priority patent/CH602710A5/de
Application filed filed Critical
Publication of HU169926B publication Critical patent/HU169926B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D203/00Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/08Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
    • C07D203/10Radicals substituted by singly bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/14Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
HUSA2805A 1974-06-19 1975-06-17 HU169926B (US07968547-20110628-C00016.png)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH838074A CH599160A5 (en) 1974-06-19 1974-06-19 Substd. 9-fluorenone and 2-indolinone derivs
CH838174A CH602710A5 (en) 1974-06-19 1974-06-19 Substd. 9-fluorenone and 2-indolinone derivs

Publications (1)

Publication Number Publication Date
HU169926B true HU169926B (US07968547-20110628-C00016.png) 1977-02-28

Family

ID=25703229

Family Applications (1)

Application Number Title Priority Date Filing Date
HUSA2805A HU169926B (US07968547-20110628-C00016.png) 1974-06-19 1975-06-17

Country Status (18)

Country Link
JP (1) JPS51125060A (US07968547-20110628-C00016.png)
AT (1) ATA466375A (US07968547-20110628-C00016.png)
AU (1) AU8216875A (US07968547-20110628-C00016.png)
CA (1) CA1036163A (US07968547-20110628-C00016.png)
DD (1) DD118086A5 (US07968547-20110628-C00016.png)
DE (1) DE2525656A1 (US07968547-20110628-C00016.png)
DK (1) DK259475A (US07968547-20110628-C00016.png)
ES (1) ES438637A1 (US07968547-20110628-C00016.png)
FI (1) FI751727A (US07968547-20110628-C00016.png)
FR (1) FR2275200A1 (US07968547-20110628-C00016.png)
GB (1) GB1500063A (US07968547-20110628-C00016.png)
HU (1) HU169926B (US07968547-20110628-C00016.png)
IE (1) IE41562B1 (US07968547-20110628-C00016.png)
IL (1) IL47503A0 (US07968547-20110628-C00016.png)
NL (1) NL7507131A (US07968547-20110628-C00016.png)
NO (1) NO752078L (US07968547-20110628-C00016.png)
SE (1) SE7506757L (US07968547-20110628-C00016.png)
SU (1) SU583755A3 (US07968547-20110628-C00016.png)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7005433B2 (en) 1999-01-22 2006-02-28 Elan Pharmaceuticals, Inc. Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
US7135477B2 (en) 2002-05-24 2006-11-14 Elan Pharmaceuticals, Inc. Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrins
US7335663B2 (en) 2002-05-24 2008-02-26 Elan Pharmaceuticals, Inc. Heteroaryl compounds which inhibit leukocyte adhesion mediated by α4 integrins
US7579466B2 (en) 2006-02-27 2009-08-25 Elan Pharmaceuticals, Inc. Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by VLA-4
US7727996B2 (en) 2005-09-29 2010-06-01 Elan Pharmaceuticals, Inc. Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4
US7763632B2 (en) 2005-09-29 2010-07-27 Elan Pharmaceuticals, Inc. Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by VLA-4

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0005828B1 (de) * 1978-06-06 1981-03-11 Hoechst Aktiengesellschaft Neue substituierte Phenylpiperazinderivate, diese enthaltende Arzneimittel und Verfahren zu deren Herstellung
MX2011011326A (es) 2009-04-27 2012-02-13 Elan Pharm Inc Antagonistas de piridinona de las integrinas alfa-4.

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7005433B2 (en) 1999-01-22 2006-02-28 Elan Pharmaceuticals, Inc. Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
US7741328B2 (en) 1999-01-22 2010-06-22 Elan Pharmaceuticals, Inc. Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
US7968547B2 (en) 1999-01-22 2011-06-28 Elan Pharmaceuticals, Inc. Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
US7973044B2 (en) 1999-01-22 2011-07-05 Elan Pharmaceuticals, Inc. Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
US7135477B2 (en) 2002-05-24 2006-11-14 Elan Pharmaceuticals, Inc. Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrins
US7335663B2 (en) 2002-05-24 2008-02-26 Elan Pharmaceuticals, Inc. Heteroaryl compounds which inhibit leukocyte adhesion mediated by α4 integrins
US7727996B2 (en) 2005-09-29 2010-06-01 Elan Pharmaceuticals, Inc. Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4
US7763632B2 (en) 2005-09-29 2010-07-27 Elan Pharmaceuticals, Inc. Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by VLA-4
US8158642B2 (en) 2005-09-29 2012-04-17 Elan Pharmaceuticals, Inc. Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4
US7579466B2 (en) 2006-02-27 2009-08-25 Elan Pharmaceuticals, Inc. Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by VLA-4
US7820687B2 (en) 2006-02-27 2010-10-26 Elan Pharmaceuticals, Inc. Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by VLA-4

Also Published As

Publication number Publication date
DK259475A (da) 1975-12-20
DD118086A5 (US07968547-20110628-C00016.png) 1976-02-12
NL7507131A (nl) 1975-12-23
FI751727A (US07968547-20110628-C00016.png) 1975-12-20
ES438637A1 (es) 1977-06-01
NO752078L (US07968547-20110628-C00016.png) 1975-12-22
JPS51125060A (en) 1976-11-01
DE2525656A1 (de) 1976-01-15
IE41562B1 (en) 1980-01-30
IL47503A0 (en) 1975-08-31
IE41562L (en) 1975-12-19
FR2275200B1 (US07968547-20110628-C00016.png) 1979-06-08
AU8216875A (en) 1976-12-23
SE7506757L (sv) 1975-12-22
CA1036163A (en) 1978-08-08
SU583755A3 (ru) 1977-12-05
FR2275200A1 (fr) 1976-01-16
GB1500063A (en) 1978-02-08
ATA466375A (de) 1979-08-15

Similar Documents

Publication Publication Date Title
FI752478A (US07968547-20110628-C00016.png)
JPS50114320A (US07968547-20110628-C00016.png)
HU169926B (US07968547-20110628-C00016.png)
FR2258596B3 (US07968547-20110628-C00016.png)
JPS50155476U (US07968547-20110628-C00016.png)
FR2272906B3 (US07968547-20110628-C00016.png)
JPS50147266A (US07968547-20110628-C00016.png)
JPS5099631U (US07968547-20110628-C00016.png)
JPS50119764U (US07968547-20110628-C00016.png)
JPS5133037A (US07968547-20110628-C00016.png)
CH583868A5 (US07968547-20110628-C00016.png)
BG22203A1 (US07968547-20110628-C00016.png)
CH582817A5 (US07968547-20110628-C00016.png)
CH579948A5 (US07968547-20110628-C00016.png)
CH571823A5 (US07968547-20110628-C00016.png)
CH568649A5 (US07968547-20110628-C00016.png)
CH567761A5 (US07968547-20110628-C00016.png)
CH583325B5 (US07968547-20110628-C00016.png)
CH565950A5 (US07968547-20110628-C00016.png)
CH575249A5 (US07968547-20110628-C00016.png)
CH561141A5 (US07968547-20110628-C00016.png)
CH1736574A4 (US07968547-20110628-C00016.png)
CH583469A5 (US07968547-20110628-C00016.png)
CH1378974A4 (US07968547-20110628-C00016.png)
BG21081A1 (US07968547-20110628-C00016.png)